Climate Change, Air Pollution, and Biodiversity in Asia Pacific and Impact on Respiratory Allergies

Ruby Pawankar,Jiu-Yao Wang
DOI: https://doi.org/10.1016/j.iac.2020.09.008
IF: 3.152
2021-02-01
Immunology and Allergy Clinics of North America
Abstract:Allergic diseases are increasing globally. Air pollution, climate change, and reduced biodiversity are major threats to human health with detrimental effects on chronic noncommunicable diseases. Outdoor and indoor air pollution and climate change are increasing. Asia has experienced rapid economic growth, a deteriorating environment, and an increase in allergic diseases to epidemic proportions. Air pollutant levels in Asian countries are substantially higher than in developed countries. Moreover, industrial, traffic-related, and household biomass combustion and indoor pollutants from chemicals and tobacco are major sources of air pollutants. We highlight the major components of pollutants and their impacts on respiratory allergies.
immunology,allergy
What problem does this paper attempt to address?
The paper aims to address the following issues: 1. **Research Background**: In patients with chronic hepatitis B (CHB) undergoing nucleos(t)ide analogues (NUCs) treatment, the virus may develop resistance mutations. These mutations not only enhance the virus's replication ability but may also lead to the emergence of vaccine escape variants (ADAPVEMs), which are hepatitis B virus mutants potentially escaping from antiviral drug-related vaccines. 2. **Specific Objectives**: To evaluate the prevalence and patterns of ADAPVEMs in Turkish patients with chronic hepatitis B. Since drugs like lamivudine are widely used for hepatitis B treatment in Turkey, such mutants may be more common and could pose a threat to both vaccinated and unvaccinated populations. Through this study, the authors hope to reveal the presence of ADAPVEMs in chronic hepatitis B patients at different stages of treatment and their potential public health risks.